The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Fibrinolysis and the control of blood coagulation
Open accessAbstract
Fibrin plays an essential role in hemostasis as both the primary product of the coagulation cascade and the ultimate substrate for fibrinolysis. Fibrinolysis efficiency is greatly influenced by clot structure, fibrinogen isoforms and polymorphisms, the rate of thrombin generation, the reactivity of thrombus-associated cells such as platelets, and the overall biochemical environment. Regulation of the fibrinolytic system, like that of the coagulation cascade, is accomplished by a wide array of cofactors, receptors, and inhibitors. Fibrinolytic activity can be generated either on the surface of a fibrin-containing thrombus, or on cells that express profibrinolytic receptors. In a widening spectrum of clinical disorders, acquired and congenital defects in fibrinolysis contribute to disease morbidity, and new assays of global fibrinolysis now have potential predictive value in multiple clinical settings. Here, we summarize the basic elements of the fibrinolytic system, points of interaction with the coagulation pathway, and some recent clinical advances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
HUMAN PLASMA PROTEINASE INHIBITORS
Travis, J., & Salvesen, G. S. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.003255 · Cited by 2,104
Okamoto, T., Schlegel, A., Scherer, P. E., & Lisanti, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5419 · Cited by 1,498
Annexins: linking Ca2+ signalling to membrane dynamics
Gerke, V., Creutz, C. E., & Moss, S. E. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1661 · Cited by 1,410
The Coagulopathy of Chronic Liver Disease
Tripodi, A., & Mannucci, P. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011170 · Cited by 1,342
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.
Hoylaerts, M., Rijken, D. C., Lijnen, H. R., & Collen, D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81051-7 · Cited by 1,312
The Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation
Esmon, C. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83649-3 · Cited by 1,046
Physiological consequences of loss of plasminogen activator gene function in mice
Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J. J., Collen, D., & Mulligan, R. C. (1994) · Nature · doi:10.1038/368419a0 · Cited by 1,037
Plasminogen activator inhibitors
Sprengers, E., & Kluft, C. (1987) · Blood · doi:10.1182/blood.v69.2.381.381 · Cited by 1,009
The Coagulopathy of Trauma: A Review of Mechanisms
Hess, J. R., Brohi, K., Dutton, R. P., Hauser, C. J., Holcomb, J. B., Kluger, Y., Mackway-Jones, K., Parr, M. J., Rizoli, S. B., Yukioka, T., et al. (2008) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e3181877a9c · Cited by 933
Molecular mechanisms of fibrinolysis
Cesarman‐Maus, G., & Hajjar, K. A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05444.x · Cited by 748
Self-citationThrombin generation and fibrin clot structure
Wolberg, A. S. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.11.001 · Cited by 747
The Regulation of Natural Anticoagulant Pathways
Esmon, C. T. (1987) · Science · doi:10.1126/science.3029867 · Cited by 697
Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor
Bajzar, L., Manuel, R., & Nesheim, M. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14477 · Cited by 680
Annexins – unique membrane binding proteins with diverse functions
Rescher, U., & Gerke, V. (2004) · Journal of Cell Science · doi:10.1242/jcs.01245 · Cited by 594
Malhotra, S. K. (1983) · Cited by 556
Undas, A., & Ariëns, R. A. S. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.230631 · Cited by 526
Platelets at work in primary hemostasis
Broos, K., Feys, H. B., De Meyer, S. F., Vanhoorelbeke, K., & Deckmyn, H. (2011) · Blood Reviews · doi:10.1016/j.blre.2011.03.002 · Cited by 502
Platelets and Thrombolytic Therapy
Coller, B. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001043220107 · Cited by 482
Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.
Bugge, T. H., Flick, M. J., Daugherty, C. C., & Degen, J. L. (1995) · Genes & Development · doi:10.1101/gad.9.7.794 · Cited by 438
Schöchl, H., Frietsch, T., Pavelka, M., & Jámbor, C. (2009) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e31818b2483 · Cited by 393
Annexin II and Bleeding in Acute Promyelocytic Leukemia
Menell, J. S., Cesarman, G. M., Jacovina, A. T., McLaughlin, M. A., Lev, E. A., & Hajjar, K. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904013401303 · Cited by 387
Self-citationEffects of Disruption of The Plasminogen Gene on Thrombosis, Growth, and Health in Mice
Ploplis, V. A., Carmeliet, P., Vazirzadeh, S., Van Vlaenderen, I., Moons, L., Plow, E. F., & Collen, D. (1995) · Circulation · doi:10.1161/01.cir.92.9.2585 · Cited by 386
New insights into the molecular mechanisms of the fibrinolytic system
RIJKEN, D. C., & LIJNEN, H. R. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03220.x · Cited by 382
Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo
Ling, Q., Jacovina, A. T., Deora, A., Febbraio, M., Simantov, R., Silverstein, R. L., Hempstead, B., Mark, W. H., & Hajjar, K. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19684 · Cited by 381
Self-citationThrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis
van Tilburg, N. H., Rosendaal, F. R., & Bertina, R. M. (2000) · Blood · doi:10.1182/blood.v95.9.2855.009k02_2855_2859 · Cited by 373
Meltzer, M. E., Lisman, T., de Groot, P. G., Meijers, J. C. M., le Cessie, S., Doggen, C. J. M., & Rosendaal, F. R. (2010) · Blood · doi:10.1182/blood-2010-02-267740 · Cited by 364
Carmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., van Nuffelen, A., Prendergast, G., Cole, M., Bronson, R., Collen, D., & Mulligan, R. C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116892 · Cited by 345
Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia
Sebastiani, P., Ramoni, M. F., Nolan, V., Baldwin, C. T., & Steinberg, M. H. (2005) · Nature Genetics · doi:10.1038/ng1533 · Cited by 334
Bleeding and Coagulopathies in Critical Care
Hunt, B. J. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1208626 · Cited by 324
FIBTEM provides early prediction of massive transfusion in trauma
Schöchl, H., Cotton, B., Inaba, K., Nienaber, U., Fischer, H., Voelckel, W., & Solomon, C. (2011) · Critical Care · doi:10.1186/cc10539 · Cited by 313
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis
Lisman, T., de Groot, P. G., Meijers, J. C. M., & Rosendaal, F. R. (2005) · Blood · doi:10.1182/blood-2004-08-3253 · Cited by 282
Annexin II tetramer: structure and function
Waisman, D. M. (1995) · Molecular and Cellular Biochemistry · doi:10.1007/bf01076592 · Cited by 273
The effect of fibrin structure on fibrinolysis.
Gabriel, D. A., Muga, K., & Boothroyd, E. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35759-4 · Cited by 269
Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation
Blombäck, B., Carlsson, K., Fatah, K., Hessel, B., & Procyk, R. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90227-5 · Cited by 259
Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia
Lak, Keihani, Elahi, Peyvandi, & Mannucci (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01681.x · Cited by 248
Novel Aspects of Fibrin(ogen) Fragments during Inflammation
Jennewein, C., Tran, N., Paulus, P., Ellinghaus, P., Eble, J. A., & Zacharowski, K. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00146 · Cited by 248
Senior, R. M., Skogen, W. F., Griffin, G. L., & Wilner, G. D. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112353 · Cited by 225
The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae.
Stahl, A., & Mueller, B. M. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.2.335 · Cited by 198
Fibrin(ogen) and thrombotic disease
Ariëns, R. A. S. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12229 · Cited by 182
SCHUSTER, V., HÜGLE, B., & TEFS, K. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02776.x · Cited by 179
PAI‐1, progress in understanding the clinical problem and its aetiology
Iwaki, T., Urano, T., & Umemura, K. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09074.x · Cited by 177
Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome
Cesarman-Maus, G., Ríos-Luna, N. P., Deora, A. B., Huang, B., Villa, R., Cravioto, M. D. C., Alarcón-Segovia, D., Sánchez-Guerrero, J., & Hajjar, K. A. (2006) · Blood · doi:10.1182/blood-2005-07-2636 · Cited by 175
Self-citationWolberg, A. S., Monroe, D. M., Roberts, H. R., & Hoffman, M. (2003) · Blood · doi:10.1182/blood-2002-08-2527 · Cited by 175
Coagulation assessment by rotation thrombelastometry in normal pregnancy
Carrabin, N., Benchaib, M., Fontaine, O., Levrat, A., Massignon, D., Touzet, S., Rudigoz, R.-C., Berland, M., & Huissoud, C. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-06-0386 · Cited by 166
Fibrinogen and red blood cells in venous thrombosis
Aleman, M. M., Walton, B. L., Byrnes, J. R., & Wolberg, A. S. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.03.017 · Cited by 166
S100A10/p11: family, friends and functions
Rescher, U., & Gerke, V. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0313-4 · Cited by 165
Longstaff, C., Thelwell, C., Williams, S. C., Silva, M. M., Szabó, L., & Kolev, K. (2010) · Blood · doi:10.1182/blood-2010-06-290338 · Cited by 151
Genetic predictors for stroke in children with sickle cell anemia
Flanagan, J. M., Frohlich, D. M., Howard, T. A., Schultz, W. H., Driscoll, C., Nagasubramanian, R., Mortier, N. A., Kimble, A. C., Aygün, B., Adams, R. J., et al. (2011) · Blood · doi:10.1182/blood-2011-01-332205 · Cited by 151
Ogawa, S., Szlam, F., Chen, E. P., Nishimura, T., Kim, H., Roback, J. D., Levy, J. H., & Tanaka, K. A. (2011) · Transfusion · doi:10.1111/j.1537-2995.2011.03241.x · Cited by 149
Tate, K. M., Higgins, D. L., Holmes, W. E., et al. (1987) · Biochemistry · doi:10.1021/bi00376a002 · Cited by 145
The Coagulopathy of Chronic Liver Disease
Tripodi, A., & Mannucci, P. M. (2012) · Survey of Anesthesiology · doi:10.1097/01.sa.0000414257.36213.3a · Cited by 143
Chemotaxis for Human Monocytes by Fibrinogen‐derived Peptides
Richardson, D. L., Pepper, D. S., & Kay, A. B. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb00953.x · Cited by 140
High dose factor VIIa improves clot structure and stability in a model of haemophilia B
Wolberg, A. S., Allen, G. A., Monroe, D. M., Hedner, U. K. E., Roberts, H. R., & Hoffman, M. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05820.x · Cited by 138
Neeves, K. B., Illing, D. A. R., & Diamond, S. L. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.4275 · Cited by 134
Fibrinogen gamma-chain splice variant γ′ alters fibrin formation and structure
Cooper, A. V., Standeven, K. F., & Ariëns, R. A. S. (2003) · Blood · doi:10.1182/blood-2002-10-3150 · Cited by 132
Activation of Coagulation and Fibrinolysis in Heatstroke
Bouchama, A., Bridey, F., Hammami, M. M., Lacombe, C., Shail, E. A., Al-Ohaly, Y., Combe, F., Al‐Sedairy, S. T., & de Prost, D. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650685 · Cited by 126
Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.
Kimura, S., & Aoki, N. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66755-9 · Cited by 124
The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival
Dougherty, K. M., Pearson, J. M., Yang, A. Y., Westrick, R. J., Baker, M. S., & Ginsburg, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.686 · Cited by 122
LIJNEN, H. R., Okada, K., Matsuo, O., et al. (1999) · Blood · doi:10.1182/blood.v93.7.2274 · Cited by 121
Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation
Sivula, M., Pettilä, V., Niemi, T., Varpula, M., & Kuitunen, A. H. (2009) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32832a76e1 · Cited by 119
The annexin A2 system and vascular homeostasis
Flood, E. C., & Hajjar, K. A. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.03.003 · Cited by 118
Self-citationThe presence and release of alpha 2-antiplasmin from human platelets
Plow, E., & Collen, D. (1981) · Blood · doi:10.1182/blood.v58.6.1069.1069 · Cited by 115
Meltzer, M. E., Lisman, T., Doggen, C. J. M., de Groot, P. G., & Rosendaal, F. R. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050097 · Cited by 114
Pharmacokinetics and safety of fibrinogen concentrate
Manco‐Johnson, M. J., DiMichele, D., Castaman, G., Fremann, S., Knaub, S., Kalina, U., Peyvandi, F., Piseddu, G., & Mannucci, P. M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03633.x · Cited by 107
Factor XIII‐mediated cross‐linking of NH2‐terminal peptide of α2‐plasmin inhibitor to fibrin
Ichinose, A., Tamaki, T., & Aoki, N. (1983) · FEBS Letters · doi:10.1016/0014-5793(83)80645-0 · Cited by 105
Schneider, M. M., & Nesheim, M. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313164200 · Cited by 93
Insights into platelet-based control of coagulation
Witt, S., Verdoold, R., Cosemans, J. M. E. M., & Heemskerk, J. W. M. (2014) · Thrombosis Research · doi:10.1016/s0049-3848(14)50024-2 · Cited by 93
Impaired Fibrinolysis in the Antiphospholipid Syndrome
Krone, K. A., Allen, K. L., & McCrae, K. R. (2010) · Current Rheumatology Reports · doi:10.1007/s11926-009-0075-4 · Cited by 91
Role of Fibrin Structure in Thrombosis and Vascular Disease
Corte, A. L. C. L., Philippou, H., & Ariëns, R. A. S. (2011) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-381262-9.00003-3 · Cited by 90
LIJNEN, H. R., Soria, J., Soria, C., Collen, D., & Caen, J. (1984) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661033 · Cited by 85
Cellular receptors for the plasminogen activators
Bu, G., Warshawsky, I., & Schwartz, A. L. (1994) · Blood · doi:10.1182/blood.v83.12.3427.3427 · Cited by 82
Coolman, M., Timmermans, S., de Groot, C. J. M., Russcher, H., Lindemans, J. W., Albert Hofman, D., Geurts-Moespot, A. J., Sweep, F. C. G. J., Jaddoe, V. W. V., & Steegers, E. A. P. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318256187f · Cited by 82
Prospective study of fibrinolytic markers and venous thromboembolism
Folsom, A. R., Cushman, M., Heckbert, S. R., Rosamond, W. D., & Aleksic, N. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00052-0 · Cited by 81
Ridker, P. M., Vaughan, D. E., Stampfer, M. J., Manson, J. E., Shen, C., Newcomer, L. M., Goldhaber, S. Z., & Hennekens, C. H. (1992) · Circulation · doi:10.1161/01.cir.85.5.1822 · Cited by 77
Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study
Roberts, J., Roberts, R., Johnston, M., Stevens, P., Skingley, P., Patrassi, G., Sartori, M. T., Hirsh, J., Prandoni, P., Weitz, J., et al. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615594 · Cited by 76
Tissue Plasminogen Activator −7351C/T Enhancer Polymorphism Is a Risk Factor for Lacunar Stroke
Jannes, J., Hamilton‐Bruce, M. A., Pilotto, L., Smith, B. J., Mullighan, C. G., Bardy, P., & Koblar, S. A. (2004) · Stroke · doi:10.1161/01.str.0000124123.76658.6c · Cited by 76
Meltzer, M. E., Doggen, C. J. M., de Groot, P. G., Rosendaal, F. R., & Lisman, T. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07569.x · Cited by 71
Dupuy, É., Habib, A., Lebret, M., Yang, R.-C., Levy-Toledano, S., & Tobelem, G. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00208.x · Cited by 71
New role of plasminogen activator inhibitor‐1 in alcohol‐induced liver injury
Arteel, G. E. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05285.x · Cited by 67
Regulation of S100A10 by the PML-RAR-α oncoprotein
O'Connell, P. A., Madureira, P. A., Berman, J. N., Liwski, R., & Waisman, D. M. (2011) · Blood · doi:10.1182/blood-2010-07-298851 · Cited by 66
Annexins as disease modifiers.
Fatimathas, L., & Moss, S. E. (2010) · PubMed · doi:10.14670/hh-25.527 · Cited by 63
Deng, A., Gocke, C. D., Hess, J. R., Heyman, M. R., Paltiel, M., & Gaspari, A. A. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.11.1466 · Cited by 61
Furie, B. (2009) · Hematology · doi:10.1182/asheducation-2009.1.255 · Cited by 60
Treatment of congenital fibrinogen disorders
de Moerloose, P., & Neerman‐Arbez, M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.979 · Cited by 47
Risk Assessment for Thrombosis in Cancer
Gomes, M. P. V.-F., & Khorana, A. A. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1370770 · Cited by 47
Nikolopoulos, G. K., Bagos, P. G., Tsangaris, I., Tsiara, C. G., Kopterides, P., Vaiopoulos, A., Kapsimali, V., Bonovas, S., & Tsantes, A. E. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-1124 · Cited by 42
Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of ischemic stroke: a meta-analysis
Tsantes, A. Ε., Nikolopoulos, G. K., Bagos, P. G., Tsiara, C. G., Kapsimali, V., Travlou, Α., & Vaiopoulos, G. (2007) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3281ec4eee · Cited by 41
Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells
Grinnell, B. W., & Berg, D. T. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.2.h603 · Cited by 38
Roesner, J. P., Petzelbauer, P., Koch, A. H., Tran, N., Iber, T., Vagts, D. A., Scheeren, T., Vollmar, B., Nöldge-Schomburg, G. E. F., & Zacharowski, K. D. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181959a12 · Cited by 38
Tàssies, D., Roqué, M., Monteagudo, J., Martorell, T., Sionís, A., Arzamendi, D., Heras, M., & Reverter, J. C. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.07.004 · Cited by 33
Lafay, M., Laguna, R., Bonniec, B. L., et al. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615076 · Cited by 33
Variable D‐dimer thresholds for diagnosis of clinically suspected acute pulmonary embolism
van der Hulle, T., den Exter, P. L., Erkens, P. M. G., van Es, J., Mos, I. C. M., Cate, H. T., Kamphuisen, P. W., Hovens, M. M. C., Buller, H. R., Klok, F. A., et al. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12394 · Cited by 27
Urokinase-Type Plasminogen Activator Deficiency Promotes Neoplasmatogenesis in the Colon of Mice
Karamanavi, E., Angelopoulou, K., Lavrentiadou, S. N., Tsingotjidou, A., Abas, Z., Taitzoglou, I., Vlemmas, I., Erdman, S. E., & Poutahidis, T. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.02.002 · Cited by 24
Shi, J., Zhi, P., Chen, J., Wu, P., & Tan, S. H. D. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.06.023 · Cited by 22
Hugenholtz, G. C. G., Meijers, J. C. M., Adelmeijer, J., Porte, R. J., & Lisman, T. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-12-0930 · Cited by 22
Urokinase plasminogen activator gene deficiency inhibits fracture cartilage remodeling
Popa, N. L., Wergedal, J. E., Lau, K. ‐. W., Mohan, S., & Rundle, C. H. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0475-4 · Cited by 20
Mazur, P. K., Sokołowski, G., Hubalewska–Dydejczyk, A., Płaczkiewicz‐Jankowska, E., & Undas, A. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.05.041 · Cited by 19
Cited by
Prevention of Intravascular Catheter-Related Infections
(2021) · Indian Journal of Continuing Nursing Education · doi:10.4103/2230-7354.320831 · Cited by 855
Edlmann, E., Giorgi-Coll, S., Whitfield, P. C., Carpenter, K. L. H., & Hutchinson, P. J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0881-y · Cited by 729
Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding
Hickman, D. A., Pawlowski, C. L., Sekhon, U. D. S., Marks, J., & Gupta, A. S. (2018) · Advanced Materials · doi:10.1002/adma.201700859 · Cited by 583
Multi-organ proteomic landscape of COVID-19 autopsies
Nie, X., Qian, L., Sun, R., Huang, B., Dong, X., Xiao, Q., Zhang, Q., Lu, T., Yue, L., Chen, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.004 · Cited by 408
NOTCH1 is a mechanosensor in adult arteries
Mack, J. J., Mosqueiro, T. S., Archer, B. J., Jones, W. M., Sunshine, H., Faas, G. C., Briot, A., Aragón, R. L., Su, T., Romay, M. C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01741-8 · Cited by 307
Metadata
- Authors
- Chapin, J. C., & Hajjar, K. A.
- Venue
- Blood Reviews
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 29
- Issue
- 1
- Pages
- 17-24
- ISSN
- 0268-960X (ISSN-L)
- OpenAlex
- W2097708776
- Cited by
- 839
- References
- 98
- FWCI
- 15.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.